Managing costs and care for chronic idiopathic constipation

Area of Science:

• Gastroenterology
• Internal Medicine
• Pharmacoeconomics

Background:

• Chronic idiopathic constipation (CIC) is a prevalent functional gastrointestinal disorder.
• CIC is associated with numerous comorbidities, including depression, diabetes, and obesity.
• It significantly impacts patient quality of life and incurs substantial healthcare costs.

Purpose of the Study:

• To review the clinical, economic, and humanistic outcomes of CIC.
• To highlight the limitations of traditional CIC treatments.
• To emphasize the benefits of newer prescription therapies and effective formulary management.

Main Methods:

• Literature review of studies on CIC prevalence, comorbidities, and treatment outcomes.
• Analysis of economic burden and patient-reported outcomes.
• Evaluation of current treatment guidelines and emerging therapeutic options.

Main Results:

• Patients with CIC experience poor general health, mental health, and social functioning.
• The average patient tries multiple treatments before finding relief, with high dissatisfaction rates.
• Newer prescription drugs demonstrate superior efficacy in symptom relief compared to traditional approaches.

Conclusions:

• Effective formulary management of CIC can improve clinical, economic, and humanistic outcomes.
• Flexible treatment plans are necessary due to prevalent patient dissatisfaction.
• Addressing CIC requires a comprehensive approach considering patient-specific needs and treatment efficacy.